BiopharmaTrend: Where Tech Meets Bio

BioPharmaTrend

AI report cover

Latest News

NVIDIA Releases Agentic AI Blueprint for Literature …

NVIDIA Releases Agentic AI Blueprint for Literature Review and Target Discovery

NVIDIA has released a new AI-driven workflow, the Biomedical AI-Q Research Agent Developer Blueprint, designed to accelerate the early phases of drug discovery by automating … Read More

Nabla Raises $70M Series C to Expand …

Nabla Raises $70M Series C to Expand Agentic AI Platform for Clinical Workflows

Nabla, developer of a widely adopted AI assistant used by over 130 healthcare organizations, has raised a $70 million Series C round led by HV … Read More

Axiom Bio Releases Human Liver Toxicity Dataset …

Axiom Bio Releases Human Liver Toxicity Dataset with 130,000 Compounds to Advance AI-based Toxicity Prediction

San Francisco-based startup Axiom Bio, previously backed by $15 million in seed funding from investors including Amplify Partners, Dimension Capital, and Zetta Ventures, has released … Read More

Xaira Publishes Largest Public Perturb-seq Atlas to Advance Virtual Cell Modeling

Agenus and Noetik Partner to Develop AI-Based Biomarkers Using Virtual Cell Models

Isomorphic Labs Appoints Ben Wolf as Chief Medical Officer, Expands to U.S. Hub in Cambridge

Ryght AI Raises $3M to Automate Clinical Trial Site Activation with Agentic AI

AstraZeneca Signs $5.3B AI Drug Discovery Deal with CSPC for Chronic Disease Programs

Insilico Medicine Completes Oversubscribed Series E, Bringing Total Funding to $123 Million

Read latest news ›››

Latest Insights

Marking the Path Ahead: Integrating Oncology Biomarkers …

by Bea Mann, PhD

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

In recent years, therapeutic capabilities in oncology have grown dramatically, with a vast array of advanced treatments progressing through clinical trials and onto the market. … Read More

Novotech Report: Over 800 Global IPF Trials …

by BiopharmaTrend

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

Novotech CRO has released a global market analysis focused on the clinical trial landscape for Idiopathic Pulmonary Fibrosis (IPF), identifying strategic trends for drug developers … Read More

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

by Adele Ruder, Alexander Hustinx, Louise von Stechow

How AI, Graphs, and GraphRAG Are Set to Revolutionize Alzheimer's Gene Research and Treatment

by Dominik Tomicevic

Novotech Report: Over 800 Global IPF Trials Since 2020, Led by Asia-Pacific

by BiopharmaTrend

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

by BiopharmaTrend

AI in Drug Safety: From Concept to Reality, The Industry's Path Forward

by Dr. Karthik Muthusamy

Marking the Path Ahead: Integrating Oncology Biomarkers Into Clinical Development

by Bea Mann, PhD

Combination Therapies May Be the Future of Oncology – How Can We Navigate Development Challenges Today?

by Andreas Dreps, Bea Mann, PhD

The Future of Advanced Therapeutics: Opportunities and Challenges

by Sai Bhamidipati

Read all insights ›››

From Our Partners

Read All ›››

Chemistry CROs at a Crossroads: How SpiroChem …

Sponsored by SpiroChem

Chemistry CROs at a Crossroads: How SpiroChem Is Adapting to Market Shifts in 2025 and Beyond

Navigating the Crossroads of AI and Oncology: …

Sponsored by Lantern Pharma

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

This AI Startup Joins Forces With NVIDIA's …

Sponsored by RECEPTOR.AI

This AI Startup Joins Forces With NVIDIA's BioNeMo to Boost Drug Discovery

AI Is Key to Democratizing Drug Discovery

Sponsored by OPTIC

AI Is Key to Democratizing Drug Discovery

Partner Events

View all events ›››

The 12th Aging Research & Drug Discovery Meeting

The 12th Aging Research & Drug Discovery Meeting

Event Date: Aug. 25, 2025 - Aug. 29, 2025

Location: Denmark (Ceremonial Hall, University of Copenhagen)

Website: Link

Interactive Response Technologies 2025

Interactive Response Technologies 2025

Event Date: Oct. 14, 2025 - Oct. 15, 2025

Location: United States of America (The Westin Copley Place, Boston, MA)

Website: Link

22nd BioPharma Drug Discovery Nexus Conference Belgium

22nd BioPharma Drug Discovery Nexus Conference Belgium

Event Date: April 29, 2026 - April 29, 2026

Location: Belgium (Brussels, Holiday Inn)

Website: Link

RNA Leaders USA Congress

RNA Leaders USA Congress

Event Date: Sept. 10, 2025 - Sept. 11, 2025

Location: United States of America (Boston Exhibition & Convention Center)

Website: Link

Case Studies

Read All ›››

QUAISAR Computational Platform for Designing Targeted Protein …

Sponsored by Roivant Sciences

QUAISAR Computational Platform for Designing Targeted Protein Degraders

Revolutionizing Clinical Trials: How AI and Automation …

Sponsored by Trialize

Revolutionizing Clinical Trials: How AI and Automation Reduced Study Build Time from Months to Days

Biocompare: Offline Order Attribution Analysis Helps Demonstrate …

Sponsored by Biocompare

Biocompare: Offline Order Attribution Analysis Helps Demonstrate Marketing Effectiveness

Using End-to-End Wet Lab Automation Combined with …

Sponsored by Arctoris

Using End-to-End Wet Lab Automation Combined with Machine Learning to Industrialize Drug Discovery

Identifying High Impact Tissue Sparing E3 Ligases …

Sponsored by Kymera Therapeutics

Identifying High Impact Tissue Sparing E3 Ligases and Their Binders

Powering Cancer Drug Discovery and Development Using …

Sponsored by Lantern Pharma

Powering Cancer Drug Discovery and Development Using the Artificial Intelligence and Machine Learning Platform RADR®

Busting the PoseBusters v3: AI Docking Software …

Sponsored by RECEPTOR.AI

Busting the PoseBusters v3: AI Docking Software ArtiDock Beats Industry’s State of the Art in Speed and Accuracy

Cyclica's Chemical Probes for DCAF1

Sponsored by Cyclica

Cyclica's Chemical Probes for DCAF1

Interviews

Read All ›››

Democratizing Early Drug Discovery through Artificial Intelligence: …

Democratizing Early Drug Discovery through Artificial Intelligence: Interview with Syntekabio CEO Jongsun Jung

Navigating the Crossroads of AI and Oncology: …

Navigating the Crossroads of AI and Oncology: A Deep Dive with Lantern Pharma's CEO, Panna Sharma

[Interview] How D-Wave Brings Quantum Computing Into …

[Interview] How D-Wave Brings Quantum Computing Into Biology

The Synergistic Potential of AI and Synthetic …

The Synergistic Potential of AI and Synthetic Biology: Interview with S&P Global’s Miriam Fernández

Most Read

5 AI-Powered Companies Transforming the Future of …

5 AI-Powered Companies Transforming the Future of Fertility Care

The CRO Industry in Flux: Navigating Technology, …

The CRO Industry in Flux: Navigating Technology, Business Models, and Trends in Pharma R&D Outsourcing

10 Companies Applying AI for Biologics Discovery

10 Companies Applying AI for Biologics Discovery

Six AI-driven Drug Discovery Companies Enabling Precision …

Six AI-driven Drug Discovery Companies Enabling Precision Oncology